Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 275
Filter
1.
Arch Pathol Lab Med ; 145(11): 1448-1452, 2021 11 01.
Article in English | MEDLINE | ID: mdl-33571371

ABSTRACT

CONTEXT.­: Endosalpingiosis is a benign Müllerian inclusion that can mimic metastatic low-grade mammary carcinoma, particularly when encountered in axillary lymph nodes excised for breast cancer staging. Immunohistochemistry can be useful in histologically ambiguous cases, and a targeted immunopanel should include a marker of gynecologic tract origin and a marker of mammary origin. GATA3 is a sensitive immunomarker for breast carcinoma, but the immunoreactivity of GATA3 in endosalpingiosis has not been systematically evaluated. OBJECTIVE.­: To evaluate whether GATA3 immunohistochemistry could be used to differentiate endosalpingiosis from metastatic mammary carcinoma. DESIGN.­: Whole slide sections of 15 cases of endosalpingiosis involving nonneoplastic tissues were subjected to GATA3 immunohistochemistry. Nuclear GATA3 labeling was scored as percentage and intensity labeling, with any labeling considered positive; GATA3 labeling was recorded in all cells present in the sections. RESULTS.­: Half (47%, n = 7 of 15) of the endosalpingiosis cases involved lymph nodes (2 axillary, 5 pelvic) and half (53%, n = 8 of 15) involved pelvic organs or soft tissue (3 myometrial, 2 paratubal, 2 periadnexal soft tissue, and 1 pelvic sidewall). GATA3 immunohistochemistry was negative in all cases of endosalpingiosis, with intact, positive control labeling in lymphocytes. The benign fallopian tube epithelium present on the sections of paratubal endosalpingiosis displayed focal (<5%), weak labeling for GATA3, specifically within the ciliated and secretory cells. CONCLUSIONS.­: These findings support the diagnostic utility of GATA3 immunohistochemistry and its use in a targeted immunopanel to resolve the differential diagnosis of metastatic low-grade mammary carcinoma (GATA3+) and nodal endosalpingiosis (GATA3-).


Subject(s)
Biomarkers, Tumor/analysis , Breast Neoplasms/chemistry , Carcinoma/chemistry , GATA3 Transcription Factor/analysis , Immunohistochemistry , Lymph Nodes/chemistry , Lymphatic Diseases/metabolism , Biopsy , Breast Neoplasms/pathology , Carcinoma/secondary , Diagnosis, Differential , Female , Humans , Lymph Node Excision , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymphatic Diseases/pathology , Lymphatic Diseases/surgery , Lymphatic Metastasis , Predictive Value of Tests
2.
Trends Cardiovasc Med ; 31(6): 333-338, 2021 08.
Article in English | MEDLINE | ID: mdl-32592746

ABSTRACT

Here we describe various techniques for visualization of the lymphatic vasculature, particularly in the heart. Addressing macro-, microscopic, and molecular levels of lymphatic organization, we give examples of how to explore the roles of specific antigens/markers expressed in lymphatic vessels and their extracellular matrix as structural and functional elements involved in various biological functions of lymphatics. Some obstacles and technical challenges related to lymphatic visualization are also discussed.


Subject(s)
Cardiac Imaging Techniques , Heart Diseases/diagnostic imaging , Heart/diagnostic imaging , Lymphatic Diseases/diagnostic imaging , Lymphatic System/diagnostic imaging , Lymphography , Microscopy , Biomarkers/metabolism , Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Glycocalyx/metabolism , Glycocalyx/pathology , Heart/physiopathology , Heart Diseases/metabolism , Heart Diseases/pathology , Heart Diseases/physiopathology , Humans , Lymphatic Diseases/metabolism , Lymphatic Diseases/pathology , Lymphatic Diseases/physiopathology , Lymphatic System/metabolism , Lymphatic System/pathology , Lymphatic System/physiopathology , Myocardium/metabolism , Myocardium/pathology , Predictive Value of Tests , Prognosis
3.
Pathol Int ; 70(6): 323-329, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32067331

ABSTRACT

The mammalian target of rapamycin (mTOR) inhibitor sirolimus is an effective treatment for difficult-to-treat lymphatic anomalies. However, little is known about the expression of mTOR pathway components in lymphatic anomalies. Here we investigated the expression pattern of mTOR pathway components and their phosphorylated forms (mTOR, p-mTOR, 4EBP1, p-4EBP1, S6K1 and p-S6K1) in normal lymphatic vessels and lymphatic anomalies using immunohistochemistry. We studied 18 patients of lymphatic anomalies, including lymphatic malformation (LM, n = 14), Kaposiform lymphangiomatosis (KLA, n = 2) and Kaposiform hemangioendothelioma (KHE, n = 2). Normal lymphatic vessels expressed 4EBP1, S6K1 and p-S6K1, but not p-4EBP1, mTOR or p-mTOR. The mTOR was detected in all lymphatic anomalies, whereas its activation form p-mTOR was detected in half cases of KLA and KHE but not in LM. All lymphatic anomalies expressed S6K1 and its activated form p-S6K1. The expression of 4EBP1 was also found in all lymphatic anomalies, but its activation was detected in approximately half of them. The activation of mTOR was seen in tumor (KLA and KHE) but not in malformation (LM), whereas the activation of S6K1 and 4EBP1 was seen in all and half of lymphatic anomalies, respectively.


Subject(s)
Lymphatic Diseases/metabolism , Lymphatic System/abnormalities , Lymphatic System/metabolism , TOR Serine-Threonine Kinases/metabolism , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Signal Transduction/physiology , Young Adult
4.
Am J Pathol ; 189(10): 1953-1972, 2019 10.
Article in English | MEDLINE | ID: mdl-31547920

ABSTRACT

Changes in the intestinal lymphatic vascular system, such as lymphatic obstruction, are characteristic features of inflammatory bowel diseases. The lymphatic vasculature forms a conduit to enable resolution of inflammation; this process is driven by specialized endogenous proresolving mediators (SPMs). To evaluate contributions of lymphatic obstruction to intestinal inflammation and to study profiles of SPMs, we generated a novel animal model of lymphatic obstruction using African green monkeys. Follow-up studies were performed at 7, 21, and 61 days. Inflammation was determined by histology. Luminex assays were performed to evaluate chemokine and cytokine levels. In addition, lipid mediator metabololipidomic profiling was performed to identify SPMs. After 7 days, lymphatic obstruction resulted in a localized inflammatory state, paralleled by an increase in inflammatory chemokines and cytokines, which were found to be up-regulated after 7 days but returned to baseline after 21 and 61 days. At the same time, a distinct pattern of SPMs was profiled, with an increase for D-series resolvins, protectins, maresins, and lipoxins at 61 days. These results indicate that intestinal lymphatic obstruction can lead to an acute inflammatory state, accompanied by an increase in proinflammatory mediators, followed by a phase of resolution, paralleled by an increase and decrease of respective SPMs.


Subject(s)
Disease Models, Animal , Inflammation Mediators/metabolism , Inflammation/metabolism , Intestinal Diseases/metabolism , Lipids/analysis , Lymphatic Diseases/metabolism , Animals , Chlorocebus aethiops , Inflammation/pathology , Intestinal Diseases/pathology , Lipid Metabolism , Lymphatic Diseases/pathology , Male
6.
Front Immunol ; 9: 2045, 2018.
Article in English | MEDLINE | ID: mdl-30245695

ABSTRACT

The early phase of systemic sclerosis (SSc) presents edema as one of the main features: this is clinically evident in the digital swelling (puffy fingers) as well as in the edematous skin infiltration of the early active diffuse subset. Other organs could be affected by this same disease process, such as the lung (with the appearance of ground glass opacities) and the heart (with edematous changes on cardiac magnetic resonance imaging). The genesis of tissue edema is tightly linked to pathological changes in the endothelium: various reports demonstrated the effect of transforming growth factor ß, vascular endothelial growth factor and hypoxia-reperfusion damage with reactive oxygen species generation in altering vascular permeability and extravasation, in particular in SSc. This condition has an alteration in the glycocalyx thickness, reducing the protection of the vessel wall and causing non-fibrotic interstitial edema, a marker of vascular leak. Moreover, changes in the junctional adhesion molecule family and other adhesion molecules, such as ICAM and VCAM, are associated with an increased myeloid cells' extravasation in the skin and increased myofibroblasts transformation with further vascular leak and cellular migration. This mini-review examines current knowledge on determinants of vascular leak in SSc, shedding light on the role of vascular protection. This could enhance further studies in the light of drug development for early treatment, suggesting that the control of vascular leakage should be considered in the same way that vasodilation and inflammation reduction, as potential therapeutic targets.


Subject(s)
Capillary Permeability , Endothelium, Vascular/metabolism , Scleroderma, Systemic/etiology , Scleroderma, Systemic/metabolism , Animals , Biomarkers , Capillaries/metabolism , Disease Susceptibility , Humans , Immune System/cytology , Immune System/immunology , Immune System/metabolism , Lymphatic Diseases/diagnosis , Lymphatic Diseases/etiology , Lymphatic Diseases/metabolism , Lymphatic Diseases/physiopathology , Scleroderma, Systemic/diagnosis , Scleroderma, Systemic/physiopathology
7.
Cancer Cytopathol ; 126(9): 797-808, 2018 09.
Article in English | MEDLINE | ID: mdl-30194715

ABSTRACT

BACKGROUND: Fine-needle aspiration with flow cytometry (FNA-FC) is routinely used in the evaluation of lymph nodes suspicious for lymphoma, yet data comparing immunophenotype distributions and outliers in benign lymph nodes sampled by fine-needle aspiration (FNA) versus excision are lacking. METHODS: Flow cytometry data from 289 benign lymph node FNA cases were assessed for the overall antigen distribution, with a focus on outliers relevant to the diagnosis of lymphoma. Distributions and outlier proportions were compared with those of a separate cohort of 298 excisional biopsies. RESULTS: Compared with excisional biopsies, FNA specimens overrepresented CD3+ events (72% vs 63%), underrepresented CD19+ events (22% vs 29%), and had 25% fewer large cell-gated events. Normalized antigen distributions in FNA were equivalent to those in excisional biopsy. Twenty-three percent of FNA-FC cases exhibited an outlier, including a skewed kappa:lambda light-chain ratio, increased CD5+ or CD10+ B-cell events, a skewed CD4:CD8 ratio, and increased CD7 loss on T cells, with no significant differences in frequency or type in comparison with excisional specimens. Outliers for the light-chain ratio and T-cell antigens were enriched among older patients and included patients with a variety of autoimmune/rheumatologic conditions. CONCLUSIONS: Benign lymph node FNA yields flow immunophenotypes remarkably similar to those from excisional biopsies. Outlier flow immunophenotypes are identified in benign lymph nodes sampled by FNA at a frequency similar to that with excisional biopsies. Older patients, who have a higher baseline risk of lymphoma, are more likely to exhibit lymphoma-mimicking outliers such as a light-chain predominance on B cells and skewed CD4:CD8 ratios or increased CD7 loss on T cells, and they warrant additional diagnostic caution.


Subject(s)
Antigens, CD/metabolism , Flow Cytometry/methods , Immunophenotyping/methods , Lymph Nodes/pathology , Lymphatic Diseases/diagnosis , Adult , Aged , Antigens, CD/immunology , Biopsy, Fine-Needle , Cohort Studies , Female , Humans , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymphatic Diseases/immunology , Lymphatic Diseases/metabolism , Male , Middle Aged
8.
Biomolecules ; 8(1)2018 01 04.
Article in English | MEDLINE | ID: mdl-29300337

ABSTRACT

Blood vessels and lymphatic vessels are located in many tissues and organs throughout the body, and play important roles in a wide variety of prevalent diseases in humans. Vascular endothelial growth factor-D (VEGF-D) is a secreted protein that can promote the remodeling of blood vessels and lymphatics in development and disease. Recent fundamental and translational studies have provided insight into the molecular mechanisms by which VEGF-D exerts its effects in human disease. Hence this protein is now of interest as a therapeutic and/or diagnostic target, or as a potential therapeutic agent, in a diversity of indications in cardiovascular medicine, cancer and the devastating pulmonary condition lymphangioleiomyomatosis. This has led to clinical trial programs to assess the effect of targeting VEGF-D signaling pathways, or delivering VEGF-D, in angina, cancer and ocular indications. This review summarizes our understanding of VEGF-D signaling in human disease, which is largely based on animal disease models and clinicopathological studies, and provides information about the outcomes of recent clinical trials testing agonists or antagonists of VEGF-D signaling.


Subject(s)
Cardiovascular Diseases/metabolism , Lung Diseases/metabolism , Lymphatic Diseases/metabolism , Neoplasms/metabolism , Vascular Endothelial Growth Factor D/metabolism , Animals , Humans , Neovascularization, Physiologic , Receptors, Vascular Endothelial Growth Factor/genetics , Receptors, Vascular Endothelial Growth Factor/metabolism , Signal Transduction , Vascular Endothelial Growth Factor D/genetics
9.
Gac Med Mex ; 152(6): 831-835, 2016.
Article in Spanish | MEDLINE | ID: mdl-27861481

ABSTRACT

Sporotrichosis is a common subcutaneous mycosis in Latin America, produced by dimorphic fungi belong to Sporothrix schenckii complex of cryptic species. Infection is acquired by traumatic inoculation with contaminated organic material. Host immune response includes polymorphonuclear neutrophils chemotaxis and release of granular components. Lactoferrin is a protein member of the transferrin family of iron-binding proteins, present inside polymorphonuclear granular structure, and has been reported to affect growth and development of infectious agents, including fungal organisms. Nevertheless, lactoferrin expression in sporotrichosis infections has not been reported yet. OBJECTIVE: To determine the expression of lactoferrin using immunohistochemical staining in sporotrichosis human infection. MATERIAL AND METHODS: The dermatology department's files during a period of five years were reviewed; cases with a diagnosis of sporotrichosis were selected and lactoferrin immunostaining was performed when enough biological material was available. RESULTS: Three cases with a diagnosis of sporotrichosis and adequate biological material on paraffin block were identified. In all cases, lactoferrin immunostaining was positive around yeast cell.


Subject(s)
Lactoferrin/metabolism , Lymphatic Diseases/metabolism , Sporotrichosis/metabolism , CD4-Positive T-Lymphocytes , Humans , Immunity, Cellular , Lactoferrin/analysis , Lymphatic Diseases/immunology , Lymphatic Diseases/microbiology , Sporothrix , Sporotrichosis/immunology , Sporotrichosis/transmission
11.
Nat Commun ; 6: 8329, 2015 Sep 21.
Article in English | MEDLINE | ID: mdl-26387913

ABSTRACT

Piezo1 ion channels are mediators of mechanotransduction in several cell types including the vascular endothelium, renal tubular cells and erythrocytes. Gain-of-function mutations in PIEZO1 cause an autosomal dominant haemolytic anaemia in humans called dehydrated hereditary stomatocytosis. However, the phenotypic consequence of PIEZO1 loss of function in humans has not previously been documented. Here we discover a novel role of this channel in the lymphatic system. Through whole-exome sequencing, we identify biallelic mutations in PIEZO1 (a splicing variant leading to early truncation and a non-synonymous missense variant) in a pair of siblings affected with persistent lymphoedema caused by congenital lymphatic dysplasia. Analysis of patients' erythrocytes as well as studies in a heterologous system reveal greatly attenuated PIEZO1 function in affected alleles. Our results delineate a novel clinical category of PIEZO1-associated hereditary lymphoedema.


Subject(s)
Anemia, Hemolytic, Congenital/metabolism , Hydrops Fetalis/metabolism , Ion Channels/metabolism , Lymphatic Diseases/metabolism , Amino Acid Sequence , Anemia, Hemolytic, Congenital/genetics , Child, Preschool , Erythrocytes/metabolism , Female , Genes, Recessive , Humans , Hydrops Fetalis/genetics , Infant , Ion Channels/chemistry , Ion Channels/genetics , Lymphatic Diseases/genetics , Male , Molecular Sequence Data , Mutation , Mutation, Missense , Sequence Alignment
12.
Medicine (Baltimore) ; 94(22): e866, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26039116

ABSTRACT

Both dermatopathic lymphadenopathy (DL) and immunoglobulin G4-related disease (IgG4-RD) are frequently complicated with allergic diseases. However, the relationship between DL and IgG4-RD is not well known. To clarify this relationship on the basis of clinical and pathological findings, including IgG4-positive (IgG4+) plasma cell infiltration in lymph nodes (LNs) of DL patients, we analyzed LNs of 11 DL patients using immunostaining of IgG, IgG4, forkhead box P3 (FOXP3), transforming growth factor (TGF)-ß, interferon (IFN)-γ, and matrix metalloproteinase (MMP)-1, MMP-8, and MMP-13. Toluidine blue staining was also performed to identify mast cells. Of 3 patients with a high ratio of IgG4+/IgG+ cells (>40%) and elevated serum IgG4 levels, 2 developed IgG4-RD, whereas the other patient did not. Of 8 patients with a low ratio of IgG4+/IgG+ cells (<40%) or no infiltration of IgG4+ cells, 5 who could be followed did not develop IgG4-RD. The numbers of mast cells were similar to those of TGF-ß-positive cells, and serial sections showed that mast cells possibly produce TGF-ß. LNs of DL patients with a high ratio of IgG4+/IgG+ cells had significantly more mast cells and TGF-ß-positive cells than those of patients with a low ratio of IgG4+/IgG+ cells or no infiltration of IgG4+ cells. However, no fibrosis was observed in LNs of both groups. IFN-γ was positive in interdigitating dendritic cells, Langerhans cells, and macrophages. MMP-1, MMP-8, or MMP-13 was expressed in macrophages. The lack of fibrosis in LNs may have been due to the production of IFN-γ, MMP-1, MMP-8, or MMP-13. Thus, DL with increased IgG4+ cells seems to be a phenotype of IgG4-RD in LNs.


Subject(s)
Immunoglobulin G/metabolism , Lymph Nodes/pathology , Lymphatic Diseases/pathology , Plasma Cells/physiology , Skin Diseases/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Forkhead Transcription Factors/metabolism , Humans , Interferon-gamma/metabolism , Lymph Nodes/metabolism , Lymphatic Diseases/etiology , Lymphatic Diseases/metabolism , Male , Matrix Metalloproteinases, Secreted/metabolism , Middle Aged , Skin Diseases/etiology , Skin Diseases/metabolism , Transforming Growth Factor beta/metabolism
13.
Ann Diagn Pathol ; 19(4): 216-20, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25979154

ABSTRACT

The potential usefulness of the squamous markers p40 and desmoglein 3 (DSG-3) for the diagnosis and staging of selected thymic lesions is uncertain. We investigated their expression and distribution pattern in 66 thymomas, 12 thymic squamous carcinomas, 6 undifferentiated thymic carcinomas, 5 hyperplastic thymi, and 5 normal thymi. p40 nuclear and DSG-3 cytoplasmic/membranous immunoreactivity in greater than or equal to 10% of thymic epithelial cells was interpreted as positive, and DSG-3 distribution pattern was classified as organotypic and nonorganotypic. All nonneoplastic thymic tissues, 100% of thymic squamous carcinomas, 97% of thymomas, and 50% of undifferentiated thymic carcinomas were positive for p40. Expression of p40 in almost all thymomas and in 50% of undifferentiated carcinomas that lacked squamous features suggests that p40 is not a good marker for the diagnosis of thymic squamous carcinoma. All normal and hyperplastic thymi, 51.5% of thymomas, and 0% of thymic squamous carcinomas expressed DSG-3 in an organotypic pattern, and 13.6% of thymomas and 83% of thymic squamous carcinomas were DSG-3 positive in a nonorganotypic pattern. Findings suggest that nonorganotypic DSG-3 expression favors the diagnosis of squamous cell carcinoma over thymoma. In 26 (60.5%) of the 43 cases where neoplastic and nonneoplastic thymus were present on the same slide, the presence/absence or distribution pattern of DSG-3 immunoreactivity was different in the 2 components, suggesting that this marker can be helpful in staging thymomas with incomplete encapsulation. The presence of DSG-3-positive and DSG-3-negative thymomas raises the possibility that these tumors may originate from 2 different types of thymic epithelial cells.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/metabolism , Desmoglein 3/metabolism , Immunodominant Epitopes/metabolism , Lymphatic Diseases/metabolism , Peptide Fragments/metabolism , Thymoma/metabolism , Thymus Neoplasms/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/pathology , Child , Child, Preschool , Desmoglein 3/analysis , Female , Humans , Immunodominant Epitopes/analysis , Immunoenzyme Techniques/methods , Lymphatic Diseases/pathology , Male , Middle Aged , Neoplasm Staging , Peptide Fragments/analysis , Thymoma/pathology , Thymus Neoplasms/pathology , Young Adult
14.
Biomed Res ; 36(2): 143-53, 2015.
Article in English | MEDLINE | ID: mdl-25876665

ABSTRACT

Proliferated IgG4(+) plasma cells are polyclonal, suggesting that the pathogenesis of IgG4-related disease (IgG4-RD) involves upstream events related to the regulation of IgG4 expansion. We hypothesized that lymphoid follicle formation may play an important role in the pathogenesis of IgG4-RD. Using various antibodies, especially against monocyte, macrophage, and follicular dendritic cell markers, we immunohistochemically assessed the distribution of immune cells in lymphoid follicles. Pathological findings of tissue samples from patients with IgG4-RD (n = 22), reactive hyperplasia (n = 3), multicentric Castleman's disease (n = 3), and Sjögren's syndrome (n = 13) were analyzed. CD14-positive lymphoid follicles were observed only in patients with IgG4-RD, and CD14-positive cells were identified as follicular dendritic cells by multicolor immunohistochemistry. There were few differences in the distributions of other cell types between the IgG4-RD and control groups. The presence of CD14(+) follicular dendritic cells in lymphoid follicles may play a pathophysiological role in IgG4-RD.


Subject(s)
Dendritic Cells, Follicular/physiology , Lipopolysaccharide Receptors/metabolism , Lymphatic Diseases/metabolism , Adult , Aged , Case-Control Studies , Female , Humans , Lymphatic Diseases/immunology , Lymphatic Diseases/pathology , Male , Middle Aged
15.
Theranostics ; 5(1): 97-109, 2015.
Article in English | MEDLINE | ID: mdl-25553101

ABSTRACT

Microbubbles have shown potential as intralymphatic ultrasound contrast agents while nanoparticle-loaded microbubbles are increasingly investigated for ultrasound-triggered drug and gene delivery. To explore whether mRNA-nanoparticle loaded microbubbles could serve as theranostics for detection of and mRNA transfer to the lymph nodes, we investigate the behavior of unloaded and mRNA-loaded microbubbles using contrast-enhanced ultrasound imaging after subcutaneous injection in dogs. Our results indicate that both types of microbubbles are equally capable of rapidly entering the lymph vessels and nodes upon injection, and novel, valuable and detailed information on the lymphatic structure in the animals could be obtained. Furthermore, additional observations were made regarding the dynamics of microbubble lymph node uptake. Importantly, neither the microbubble migration distance within the lymphatics, nor the observed contrast signal intensity was influenced by mRNA-loading. Although further optimization of acoustic parameters will be needed, this could represent a first step towards ultrasound-guided, ultrasound-triggered intranodal mRNA delivery using these theranostic microbubbles.


Subject(s)
Dog Diseases/diagnosis , Dog Diseases/metabolism , Gene Transfer Techniques , Lymphatic Diseases/veterinary , Microbubbles/therapeutic use , RNA, Messenger/pharmacokinetics , Animals , Contrast Media/metabolism , Dog Diseases/diagnostic imaging , Dogs , Female , Lymphatic Diseases/diagnosis , Lymphatic Diseases/diagnostic imaging , Lymphatic Diseases/metabolism , Male , Nanoparticles/metabolism , Ultrasonography
16.
Am J Physiol Gastrointest Liver Physiol ; 308(7): G634-42, 2015 Apr 01.
Article in English | MEDLINE | ID: mdl-25617349

ABSTRACT

Apolipoprotein A-V (apoA-V), a liver-synthesized apolipoprotein discovered in 2001, strongly modulates fasting plasma triglycerides (TG). Little is reported on the effect of apoA-V on postprandial plasma TG, an independent predictor for atherosclerosis. Overexpressing apoA-V in mice suppresses postprandial TG, but mechanisms focus on increased lipolysis or clearance of remnant particles. Unknown is whether apoA-V suppresses the absorption of dietary lipids by the gut. This study examines how apoA-V deficiency affects the steady-state absorption and lymphatic transport of dietary lipids in chow-fed mice. Using apoA-V knockout (KO, n = 8) and wild-type (WT, n = 8) lymph fistula mice, we analyzed the uptake and lymphatic transport of lipids during a continuous infusion of an emulsion containing [(3)H]triolein and [(14)C]cholesterol. ApoA-V KO mice showed a twofold increase in (3)H (P < 0.001) and a threefold increase in (14)C (P < 0.001) transport into the lymph compared with WT. The increased lymphatic transport was accompanied by a twofold reduction (P < 0.05) in mucosal (3)H, suggesting that apoA-V KO mice more rapidly secreted [(3)H]TG out of the mucosa into the lymph. ApoA-V KO mice also produced chylomicrons more rapidly than WT (P < 0.05), as measured by the transit time of [(14)C]oleic acid from the intestinal lumen to lymph. Interestingly, apoA-V KO mice produced a steadily increasing number of chylomicron particles over time, as measured by lymphatic apoB output. The data suggest that apoA-V suppresses the production of chylomicrons, playing a previously unknown role in lipid metabolism that may contribute to the postprandial hypertriglyceridemia associated with apoA-V deficiency.


Subject(s)
Apolipoproteins/deficiency , Chylomicrons/metabolism , Duodenum/metabolism , Fistula/metabolism , Lymph/metabolism , Lymphatic Diseases/metabolism , Lymphatic System/metabolism , Administration, Oral , Animals , Apolipoprotein A-V , Apolipoproteins/genetics , Cholesterol/administration & dosage , Cholesterol/metabolism , Disease Models, Animal , Fistula/genetics , Intestinal Absorption , Lymphatic Diseases/genetics , Male , Mice, Inbred C57BL , Mice, Knockout , Postprandial Period , Time Factors , Triolein/administration & dosage , Triolein/metabolism , Up-Regulation
18.
Curr Top Dev Biol ; 110: 153-87, 2014.
Article in English | MEDLINE | ID: mdl-25248476

ABSTRACT

As members of the basic helix-loop-helix (bHLH) family of transcription factors, E proteins function in the immune system by directing and maintaining a vast transcriptional network that regulates cell survival, proliferation, differentiation, and function. Proper activity of this network is essential to the functionality of the immune system. Aberrations in E protein expression or function can cause numerous defects, ranging from impaired lymphocyte development and immunodeficiency to aberrant function, cancer, and autoimmunity. Additionally, disruption of inhibitor of DNA-binding (Id) proteins, natural inhibitors of E proteins, can induce additional defects in development and function. Although E proteins have been investigated for several decades, their study continues to yield novel and exciting insights into the workings of the immune system. The goal of this chapter is to discuss the various classical roles of E proteins in lymphocyte development and highlight new and ongoing research into how these roles, if compromised, can lead to disease.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Lymphatic Diseases/metabolism , Lymphocytes/physiology , Animals , Autoimmune Diseases/genetics , Autoimmune Diseases/metabolism , Autoimmune Diseases/pathology , Basic Helix-Loop-Helix Transcription Factors/chemistry , Basic Helix-Loop-Helix Transcription Factors/genetics , Cell Differentiation , Cell Survival , Humans , Lymphatic Diseases/genetics , Lymphatic Diseases/pathology , Lymphocytes/cytology , Neoplasms/genetics , Neoplasms/metabolism , Neoplasms/pathology , Receptors, Antigen/metabolism
19.
Acta pediatr. esp ; 72(8): e285-e287, sept. 2014. ilus
Article in Spanish | IBECS | ID: ibc-129461

ABSTRACT

La linfadenopatía por picadura de garrapata (TIBOLA, por sus siglas en inglés: tick-borne lymphadenopathy) es una enfermedad emergente causada por Rickettsia slovaca. Es una zoonosis transmitida por la picadura de la garrapata Dermacentor marginatus. Los pacientes afectados presentan una escara necrótica rodeada de un halo eritematoso en el cuero cabelludo, así como adenopatías regionales dolorosas. Presentamos el caso de una niña de 4 años de edad con escara necrótica y linfadenopatías cervicales dolorosas tras una picadura de garrapata (AU)


Tick-borne lymphadenopathy (TIBOLA) is an emerging dise­ase caused by Rickettsia slovaca. It is a zoonoses transmitted to humans by Dermacentor marginatus tick-bite. Patients presents with a necrotic eschar surrounded by a perilesional erythematous halo on the scalp and painful regional lymphadenopathies. We present a case of a 4-years old girl with necrotic eschar on the scalp and painful cervical lymphadenopathy after tick bite (AU)


Subject(s)
Humans , Female , Child , DNA Degradation, Necrotic , Lymphatic Diseases/blood , Lymphatic Diseases/metabolism , Lymphatic Diseases/mortality , Lymphatic Diseases/complications , Lymphatic Diseases/diagnosis , Zoonoses/diagnosis , Pressure Ulcer/complications
20.
Arch Pathol Lab Med ; 138(8): 1059-66, 2014 Aug.
Article in English | MEDLINE | ID: mdl-25076294

ABSTRACT

CONTEXT: Pneumatosis cystoides intestinalis (PCI) is a condition with multiple gas-filled cysts within the bowel wall, associated with diverse background diseases. Its pathogenesis is still a mystery. Some previous observations scattered in the literature have suggested an association of the cystic spaces in PCI with the lymphatics. OBJECTIVE: To further investigate whether PCI results from the ballooning of gas-filled lymphatic channels. DESIGN: We did immunostaining of podoplanin, a mucoprotein preferentially expressed in lymphatic endothelial cells, in 13 cases (8 men, 5 women; age range, 18-80 years) of PCI. Ten cases were diagnosed in resected segments of bowel and 3 in biopsies. Pneumatosis was seen in the right side of the colon (9 cases), transverse colon (1 case), sigmoid colon (1 case), and small bowel (2 cases). In addition, immunostaining for CD31, calretinin, WT1, CD68, smooth muscle actin, desmin, vimentin, and cytokeratins was also performed for comparison and correlation. RESULTS: A strong immunopositivity of podoplanin was seen in a condensed linear structure in the pericystic interstitium in 100% of the cases, but was not seen in the overlying giant and flat cells that were all CD68-positive histiocytes. Meanwhile, the podoplanin-expressing structure was negative for calretinin and WT1, which ruled out the possible mesothelial origin. There were coexistent variable immunopositivity of smooth muscle actin, which suggests an admixture of myofibroblasts. These findings indicated that the PCI cases were gas-distended lymphatics with the lymphatic epithelium ruptured and embedded in the reactive histiocytes and giant cells. CONCLUSION: Our findings support the lymphatic theory about the pathogenesis of PCI.


Subject(s)
Endothelium, Lymphatic/pathology , Lymphatic Diseases/physiopathology , Lymphatic System/pathology , Pneumatosis Cystoides Intestinalis/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers/metabolism , Colon/metabolism , Colon/pathology , Colon/surgery , Dilatation, Pathologic , Endothelium, Lymphatic/metabolism , Extracellular Space/metabolism , Female , Humans , Immunohistochemistry , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Intestinal Mucosa/surgery , Intestine, Small/metabolism , Intestine, Small/pathology , Intestine, Small/surgery , Lymphatic Diseases/metabolism , Lymphatic Diseases/pathology , Lymphatic System/metabolism , Male , Membrane Glycoproteins/metabolism , Middle Aged , Pneumatosis Cystoides Intestinalis/surgery , Retrospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...